The latest happenings of the industry from the past month.
WCG announced that Carsten Henke has joined the company as Senior Vice President, Europe and Managing Director, Germany.
Former Chief Commercial Officer, Jeremy Edwards, has been appointed CEO of Raremark and former Head of Product, Alex Garner, has become COO.
ActiGraph announced the hiring of Kuno van der Post as Chief Commercial Officer, Lynda Barr as Chief Financial Officer, and Scott Ginnetti as Vice President of Human Resources and Culture.
Medable Inc announced several new hires including Mary Costello as Head of Site and Investigator Network, Rasmus Hogreffe as VP of Decentralized Trial Innovation, Steve Lesser as VP of Partner Strategy, Heidi Pfefferkorn as Decentralized Solutions Leader, Eric Peper as Executive VP of Sales, David Swanger as Senior VP of Marketing, and Ching Tian as Senior VP of Strategy & Solutions.
Veeva Systems announced that more than 500 in over 30 countries are using Veeva SiteVault Free.
Oracle Health Sciences, for the 4th year in a row, has been named a “Leader” in the Everest Group Clinical Development Platforms Products PEAK Matrix Assessment 2020. Oracle also maintained its position as the highest positioned vendor in “Vision and Capability” and took the highest position for “Market Impact.”
Syneos Health announced that it was awarded the Society for Clinical Research Sites (SCRS) Eagle Award, for the fourth consecutive year.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.